Selected article for: "drug target and therapeutic approach"
Author: Suganya, Sakthivel; Divya, Suresh; Parani, Madasamy
Title: Severe acute respiratory syndrome‐coronavirus‐2: Current advances in therapeutic targets and drug development
  • Cord-id: qcofy3kz
  • Document date: 2020_9_23
    • ID: qcofy3kz
    Snippet: The current pandemic of severe acute respiratory syndrome‐coronavirus‐2 (SARS‐CoV‐2) has quickly emerged as a global health concern with government bodies worldwide taking drastic control measures. Understanding the virology of SARS‐CoV‐2, its molecular mechanisms, and its pathogenesis are required for a targeted therapeutic approach. In this review, we highlight the current molecular and drug advances that target SARS‐CoV‐2 at the genome level. We also summarize studies that the
    Document: The current pandemic of severe acute respiratory syndrome‐coronavirus‐2 (SARS‐CoV‐2) has quickly emerged as a global health concern with government bodies worldwide taking drastic control measures. Understanding the virology of SARS‐CoV‐2, its molecular mechanisms, and its pathogenesis are required for a targeted therapeutic approach. In this review, we highlight the current molecular and drug advances that target SARS‐CoV‐2 at the genome level. We also summarize studies that therapeutically target the host angiotensin‐converting enzyme 2 and proteases. Finally, we summarize antibody‐mediated therapeutic approaches, as well as recent trends in vaccine development. Hence, the purpose of this study is to investigate different molecular targets in SARS‐CoV‐2 pathogenesis and their usefulness in developing strategies for drug development.

    Search related documents:
    Co phrase search for related documents
    • abundant expression and acute respiratory distress syndrome: 1, 2, 3
    • abundant expression and acute respiratory distress syndrome ards: 1
    • abundant expression and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • abundant expression and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abundant expression and acute respiratory syndrome sars: 1, 2, 3, 4, 5, 6
    • abundant expression and lung injury: 1
    • accessory protein and acute ards respiratory distress syndrome: 1
    • accessory protein and acute ards respiratory distress syndrome pneumonia: 1
    • accessory protein and acute lung injury: 1
    • accessory protein and acute respiratory distress syndrome: 1, 2, 3
    • accessory protein and acute respiratory distress syndrome ards: 1
    • accessory protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48
    • accessory protein and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
    • accessory protein and acute respiratory syndrome sars: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
    • accessory protein and lung injury: 1, 2
    • accessory protein and mabs specific: 1
    • accessory protein structural protein and acute respiratory distress syndrome: 1
    • accessory protein structural protein and acute respiratory syndrome: 1, 2, 3, 4
    • accessory protein structural protein and acute respiratory syndrome coronavirus: 1, 2, 3, 4